https://www.selleckchem.com/products/cm-4620.html
These findings clarify the mechanism of cross-priming of cancer antigens by DCs, allowing for a greater understanding of antitumor immune responses. Use of real-time continuous glucose monitoring (RT-CGM) systems in the inpatient setting is considered investigational. The objective of this study was to evaluate whether RT-CGM, using the glucose telemetry system (GTS), can prevent hypoglycemia in the general wards. In a randomized clinical trial, insulin-treated patients with type 2 diabetes at high risk for hypoglycemia were recruited.
Like
Comment
Share
